Association of Mannose‐Binding Lectin Deficiency with Acute Invasive Aspergillosis in Immunocompromised Patients
Jonathan Lambourne(St. George's University), Thomas S. Harrison(Sheffield Teaching Hospitals NHS Foundation Trust), P. Lewis White(University Hospital of Wales), Aby Buchbinder(Enzon Pharmaceuticals (United States)), Raoul Herbrecht(Institut de Cancérologie Strasbourg), Jodi A. Lindsay(Royal Veterinary College), Sarah Doffman(St Bartholomew's Hospital), Peter F. Troke, Dan Agranoff(Imperial College London), Samir Agrawal(St Bartholomew's Hospital), George E. Griffin(St George's Hospital), Fenella Willis(St George's Hospital), Rosemary A. Barnes(Innsbruck Medical University), Valérie Letscher‐Bru, Elizabeth M. Johnson(Bristol-Myers Squibb (Germany))
Cited by 87
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
|Clinical Infectious Diseases|2019|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k